This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Carbohydrate Metabolism, Inborn Errors
|
Concept
|
Carotenoids
|
Concept
|
Galactosemias
|
Concept
|
Interleukin-6
|
Concept
|
beta Carotene
|
Concept
|
Caspase 3
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Anticholesteremic Agents
|
Concept
|
Vitamin A
|
Academic Article
|
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
|
Academic Article
|
Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis.
|
Academic Article
|
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
|
Academic Article
|
Vinculin-actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth.
|
Academic Article
|
Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin.
|
Academic Article
|
The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature.
|
Academic Article
|
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
|
Academic Article
|
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
|
Academic Article
|
Reducing residual cardiovascular risk with novel therapies.
|
Academic Article
|
Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
|
Academic Article
|
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
|
Academic Article
|
Recent advances and emerging therapies in management of dyslipidemias.
|
Academic Article
|
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
|
Academic Article
|
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
|
Academic Article
|
How I treat statin-associated side effects in an outpatient setting.
|
Academic Article
|
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials.
|
Academic Article
|
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
|
Academic Article
|
The clinical black, white, and gray lessons.
|
Academic Article
|
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
|
Academic Article
|
Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition.
|
Academic Article
|
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
|
Academic Article
|
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
|
Academic Article
|
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
|